Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Molecular Targeted Therapy. Found 14 abstracts

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017 Aug;40(4):393-8.   PMCID: PMC5026539
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, Decamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Apr;15(4):504-35.
Shah JJ, Jakubowiak AJ, O'Connor OA, Orlowski RZ, Harvey RD, Smith MR, Lebovic D, Diefenbach C, Kelly K, Hua Z, Berger AJ, Mulligan G, Faessel HM, Tirrell S, Dezube BJ, Lonial S. Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. Clin Cancer Res. 2016 Jan;22(1):34-43.
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54.   PMCID: PMC4898971
Khalili K, Kaminski R, Gordon J, Cosentino L, Hu W. Genome editing strategies: potential tools for eradicating HIV-1/AIDS. Journal of neurovirology. 2015 Jun;21(3):310-21.   PMCID: PMC4433555
Prudnikova TY, Rawat SJ, Chernoff J. Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases. Clinical Cancer Research. 2015 Jan;21(1):24-9.   PMCID: 4286478
Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct;16(13):e510-21.
Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M. Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy. J Clin Oncol. 2014 Sep;32(25):e88-91.   PMCID: 4876358
Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):437-46.
Boland PM, Burtness B. Esophageal carcinoma: are modern targeted therapies shaking the rock?. Curr Opin Oncol. 2013 Jul;25(4):417-24.   PMCID: No NIH funding
Movva S. Emerging therapies for sarcoma. Curr Probl Cancer. 2013 Mar;37(2):87-101.   PMCID: Review
Vadakara J, von Mehren M. Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies. Hematol Oncol Clin North Am. 2013 Oct;27(5):905-20.   PMCID: Pmc3792495
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Molecular Targeted Therapy

Molecular Targeted Therapy therapeutic use drug therapy pathology Antineoplastic Agents metabolism genetics drug effects therapy antagonists & inhibitors Treatment Outcome Signal Transduction methods Protein Kinase Inhibitors pharmacology mortality diagnosis enzymology Lung Neoplasms Immunotherapy Neoplasm Drug Resistance Middle Aged Non-Small-Cell Lung Carcinoma Combined Modality Therapy immunology Clinical Trials as Topic Esophageal Neoplasms Receptor Protein-Tyrosine Kinases Antineoplastic Combined Chemotherapy Protocols secondary etiology adverse effects Cell Cycle Proteins Female Biomarkers Quinazolines Cell Proliferation Aged administration & dosage Neoplasm Metastasis Adult Neoplasms Head and Neck Neoplasms Male Triple Negative Breast Neoplasms Monoclonal Antibodies Ribonucleases Blood-Brain Barrier Esophagogastric Junction Gastrointestinal Stromal Tumors Epithelial-Mesenchymal Transition Prognosis Pyrimidines human papillomavirus Diffusion of Innovation Viral RNA Fluorouracil Tumor Microenvironment Therapeutic targets Phenotype United States Retreatment immunotherapy Hsp90 Anti-Retroviral Agents Capillary Permeability Ductal Carcinoma-Breast National Cancer Institute (US) Urologic Neoplasms Lymphoma Translational Medical Research Immunologic Factors Natural products Inflammatory Breast Neoplasms Carboplatin Mutation Neoplastic Stem Cells Pyrazoles Cancer stem cells checkpoint inhibitors Pdgfra Maximum Tolerated Dose Central Nervous System Neoplasms Genetic Predisposition to Disease Genetic Therapy Gastrointestinal Neoplasms Soft Tissue Neoplasms surgery Viral Genome Patient Selection head and neck cancer Clustered Regularly Interspaced Short Palindromic Repeats rho GTP-Binding Proteins 80 and over Aged Acquired Immunodeficiency Syndrome Disease-Free Survival Proliferation SDH-deficient GIST Carcinogenesis Kit Cancer hallmarks Cell Cycle Checkpoints Disease Management Local Neoplasm Recurrence trends Gene Rearrangement Recurrence Neoplasm Staging HIV-1 Pyridines Carcinoma Adjuvant Radiotherapy Drug Monitoring Tumor Biomarkers Piperidines Sarcoma Phosphotransferases Urothelium Esophagectomy Cyclopentanes Drug Administration Schedule Paclitaxel Multiple Myeloma Tyrosine kinase inhibitors biosynthesis Gist Ubiquitins ErbB-2 Receptor clinical trials Brain Neoplasms Igf-1r Adenocarcinoma
Last updated on Monday, November 05, 2018